Drug Shortage Report for PMS-CYTARABINE
Report ID | 7353 |
Drug Identification Number | 02406772 |
Brand name | PMS-CYTARABINE |
Common or Proper name | CYTARABINE |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | CYTARABINE |
Strength(s) | 100MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRATHECAL INTRAVENOUS SUBCUTANEOUS |
Packaging size | 20 |
ATC code | L01BC |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-04-19 |
Estimated end date | 2017-06-02 |
Actual end date | 2017-06-08 |
Shortage status | Resolved |
Updated date | 2017-06-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-04-20 | English | Compare |
v2 | 2017-04-20 | French | Compare |
v3 | 2017-05-02 | English | Compare |
v4 | 2017-05-02 | French | Compare |
v5 | 2017-06-09 | English | Compare |
v6 | 2017-06-09 | French | Compare |
Showing 1 to 6 of 6